Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q3 2026 › vs Q3 2025
Cardio Diagnostics Holdings (CDIO) Q3 2026 vs Q3 2025 (year over year)
Cardio Diagnostics Holdings's revenue rose $1K (+26%) from $3K in Q3 2025 to $4K in Q3 2026.
Cardio Diagnostics Holdings, Q3 2026: revenue $4K (+26% year over year), net loss $1.7M, operating cash flow −$1.5M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $4K | $3K | $1K | +26% |
| Net loss | $1.7M | $1.7M | $18K | +1% |
| Costs & expenses | $1.7M | $1.7M | $19K | +1% |
| Operating costs | $1.7M | $1.7M | $19K | +1% |
| Interest & other, net | $2K | $3K | −$1K | -26% |
| Operating cash sources | $1.7M | $1.7M | $18K | +1% |
| Depreciation & amortization | $6K | $6K | $324 | +6% |
| Share-based compensation | $24K | $25K | −$424 | -2% |
| Working capital & other | $186K | $291K | −$105K | -36% |
| Cash used in operations | $1.5M | $1.4M | $122K | +9% |
| Net loss absorbed | $1.7M | $1.7M | $18K | +1% |
Questions
How much did Cardio Diagnostics Holdings's revenue grow year over year in Q3 2026?
Cardio Diagnostics Holdings's revenue rose $1K (+26%) from $3K in Q3 2025 to $4K in Q3 2026.